Tokyo Tape
Sign in
← Towa Pharmaceutical

Quarterly report · Q2

4553.TEDINET S100PLZ1
Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
MetricValuePeriodScopeSource row
Revenue¥90.5bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥165.6bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥82.3bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥3.2bn2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥10.3bn2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥4.6bn2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥22.7bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥13.0bn2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥4.6bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥13.0bn2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥2.7bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥15.9bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥9.2bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥2.7bn2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥9.2bn2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥351.7bnat 2022-09-30Cons.Assets
Total assets¥332.1bnat 2022-03-31Cons.Assets
Total assets¥252.9bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥212.9bnat 2022-09-30Cons.Liabilities
Total liabilities¥199.9bnat 2022-03-31Cons.Liabilities
Net assets / equity¥138.7bnat 2022-09-30Cons.Net assets
Net assets / equity¥132.2bnat 2022-03-31Cons.Net assets
Net assets / equity¥126.4bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥30.4bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥32.8bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥30.4bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥32.8bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥24.4bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥22.9bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow−¥1.7bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥22.1bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥14.3bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥8.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥59.7bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥9.3bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow¥6.7bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow¥46.5bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥3.7bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥54.72022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥26.792022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥323.362021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥187.792021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥79.872021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥316.192021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥183.632021-04-01 → 2021-09-30Cons.Diluted earnings per share (5-year summary)
Equity ratio39.5%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio39.8%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio50.0%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥2.0bn
jpcrp040300-q2r_E00974-000Domesticreportable segmentrevenue2022-04-01 → 2022-09-30¥70.6bn
jpcrp040300-q2r_E00974-000Domesticreportable segmentrevenue external2022-04-01 → 2022-09-30¥70.6bn
jpcrp040300-q2r_E00974-000Domesticreportable segmentsegment profit2022-04-01 → 2022-09-30¥5.0bn
jpcrp040300-q2r_E00974-000Overseasreportable segmentrevenue2022-04-01 → 2022-09-30¥19.9bn
jpcrp040300-q2r_E00974-000Overseasreportable segmentrevenue external2022-04-01 → 2022-09-30¥19.9bn
jpcrp040300-q2r_E00974-000Overseasreportable segmentsegment profit2022-04-01 → 2022-09-30¥217m
—segment totalrevenue2022-04-01 → 2022-09-30¥90.5bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥90.5bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥5.3bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥400m
jpcrp040300-q2r_E00974-000Domesticreportable segmentrevenue2021-04-01 → 2021-09-30¥64.0bn
jpcrp040300-q2r_E00974-000Domesticreportable segmentrevenue external2021-04-01 → 2021-09-30¥64.0bn
jpcrp040300-q2r_E00974-000Domesticreportable segmentsegment profit2021-04-01 → 2021-09-30¥10.4bn
jpcrp040300-q2r_E00974-000Overseasreportable segmentrevenue2021-04-01 → 2021-09-30¥18.3bn
jpcrp040300-q2r_E00974-000Overseasreportable segmentrevenue external2021-04-01 → 2021-09-30¥18.3bn
jpcrp040300-q2r_E00974-000Overseasreportable segmentsegment profit2021-04-01 → 2021-09-30¥274m
—segment totalrevenue2021-04-01 → 2021-09-30¥82.3bn
—segment totalrevenue external2021-04-01 → 2021-09-30¥82.3bn
—segment totalsegment profit2021-04-01 → 2021-09-30¥10.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 496
ItemContextValueUnit
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember－JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E00974-000DomesticReportableSegmentsMember63984000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E00974-000OverseasReportableSegmentsMember18270000000JPY
Net salesPrior1YTDDuration_ReportableSegmentsMember82254000000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember－JPY
Net salesPrior1YTDDuration82254000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E00974-000DomesticReportableSegmentsMember10438000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E00974-000OverseasReportableSegmentsMember274000000JPY
Operating incomePrior1YTDDuration_ReportableSegmentsMember10712000000JPY
Operating incomePrior1YTDDuration_ReconcilingItemsMember-400000000JPY
Operating incomePrior1YTDDuration10312000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E00974-000DomesticReportableSegmentsMember70597000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E00974-000OverseasReportableSegmentsMember19902000000JPY
Revenues from external customersCurrentYTDDuration_ReportableSegmentsMember90500000000JPY
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYTDDuration90500000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E00974-000DomesticReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E00974-000OverseasReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_ReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_ReconcilingItemsMember－JPY
Transactions with other segmentsCurrentYTDDuration－JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E00974-000DomesticReportableSegmentsMember70597000000JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E00974-000OverseasReportableSegmentsMember19902000000JPY
Net salesCurrentYTDDuration_ReportableSegmentsMember90500000000JPY
Net salesCurrentYTDDuration_ReconcilingItemsMember－JPY
Net salesCurrentYTDDuration90500000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E00974-000DomesticReportableSegmentsMember5048000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E00974-000OverseasReportableSegmentsMember217000000JPY
Operating incomeCurrentYTDDuration_ReportableSegmentsMember5265000000JPY
Operating incomeCurrentYTDDuration_ReconcilingItemsMember-2045000000JPY
Operating incomeCurrentYTDDuration3220000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の4の7第1項
Place of filing cover pageFilingDateInstant
Original text (Japanese)近畿財務局長
Filing date cover pageFilingDateInstant2022-11-14
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第67期第2四半期（自　2022年7月1日　至　2022年9月30日）
Company name cover pageFilingDateInstant
Original text (Japanese)東和薬品株式会社
Company name in english cover pageFilingDateInstantTOWA PHARMACEUTICAL CO., LTD.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　　吉田　逸郎
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)大阪府門真市新橋町2番11号
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)06（6900）9100（代表）
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役　　田中　政男
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)大阪府門真市新橋町2番11号
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)06（6900）9100（代表）
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役　　田中　政男
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE00974
Fund codeFilingDateInstant－
Security codeFilingDateInstant45530

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass